Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01499394Recruiting

Caris Biorepository Research Protocol

Role: lead

NCT03324841Unknown

POA Prospective Repository

Role: lead

NCT02678754Terminated

Caris Molecular Intelligence Registry

Role: lead

NCT03326479Unknown

POA Retrospective Repository

Role: lead

NCT01499381Completed

EMBRACE1: Prostate Biorepository

Role: lead

All 5 trials loaded